Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting…
Blog
Averix Bio, a Botanical-based Cannabinoid Supplier, Achieves cGMP 21 CFR Part 210 and Part 211 and ICH Q7 Compliance
Averix Bio is proud to announce that it has successfully completed an independent audit for 21 CFR…
SOPHiA GENETICS offers new genomic application for a deeper investigation of Mendelian diseases
SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that…
Ignore No More: Foundation for Sarcoidosis Research Launches African American Women & Sarcoidosis Campaign
The Foundation for Sarcoidosis Research (FSR) is excited to announce the official launch of the first…
Innovative Partnership with OSMS to improve Workers’ Compensation Outcomes and lower healthcare costs
Trilogy Health Solutions announced today that Orthopedic and Sports Medicine Specialists (OSMS) will participate in their…
AANA Underscores Need for Policies to Improve Competition in Healthcare in Letter to Biden Administration
In an Oct. 5 letter to President Biden, American Association of Nurse Anesthesiology (AANA) President Dina Velocci, DNP, CRNA,…
Global Pharmaceutical Analytical Testing Outsourcing Market Report 2021
The “Global Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report by Service (Bioanalytical, Stability…
Intelivideo Announces Partnership with Matrix Fitness, Elevating the Omnichannel Workout Experience for Fitness Enthusiasts Worldwide
Intelivideo, a Video on Demand (VOD) and digital technology platform for the health and wellness industry,…
Dr. Charlie Seltzer Transforms Philadelphia’s Health and Wellness Scene With New Space and Services
Philadelphia’s top weight loss doctor—and the only physician in the country to be both board certified…
Oblique Therapeutics is excited to present the recent progress on its anti-Thioredoxin mAb program at the annual meeting of Society for Immunotherapy of Cancer, Nov 10 – 14, Washington DC, USA
Oblique Therapeutics, a biotech focused on new medicines for severe diseases with large unmet medical needs,…